Polytherapy in the preventive and acute treatment of migraine: fundamentals for changing the approach

References

• Stewart WF, Schechter A, Lipton RB. Migraine heterogeneity, disability, pain intensity and attack frequency and duration. Neurology 44(Suppl. 4), S24–S39 (1994).
   PubMed Web of Science ®Google Scholar
• Rasmussen BK. Epidemiology of headache. Cephalalgia 15, 45–68 (1995).
   PubMed Web of Science ®Google Scholar
• Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders. 2nd edition. Cephalalgia 24(Suppl. 1), 1–160 (2004).
   Web of Science ®Google Scholar
• Stewart WF, Lipton RB, Simon D. Work-related disability: results from the American migraine study. Cephalalgia 16, 231–238 (1996).
   PubMed Web of Science ®Google Scholar
• Lipton RB, Stewart WF. Prevalence and impact of migraine. Neurol. Clin. 15, 1–13 (1997).
   PubMed Web of Science ®Google Scholar
• Goadsby PJ, Lipton RB, Ferrari MD. Migraine – current understanding and treatment. N. Engl. J. Med. 346, 257–270 (2002).
   PubMed Web of Science ®Google Scholar
• Tfelt-Hansen P, Welch KMA. General principles of pharmacological treatment of migraine. In: The Headaches. 2nd Edition. Olesen J, Tfelt-Hansen P, Welch KMA (Eds), Lippincott Willians & Wilkins, PA, USA, 385–389 (2000).
   Google Scholar
• Silberstein SD, Saper JR, Freitag FG. Migraine: diagnosis and treatment. In: Wolff’s Headache and Other Head Pain. 7th Edition. Silberstein SD, Lipton RB, Dalessio DJ (Eds), Oxford University Press, NY, USA, 121–246 (2001).
   Google Scholar
• Bordini CA, Arruda MA, Cicciarelli MC, Speciali JG. Propranolol vs flunarizine vs flunarizine plus propranolol in migraine without aura prophylaxis. A double-blind trial. Arq. Neuropsiquiatr. 55(3B), 536–541 (1997).
   PubMedGoogle Scholar
• Pascual J, Leira R, Lainez JM. Combined therapy for migraine prevention? Clinical experience with a β-blocker plus sodium valproate in 52 resistant migraine patients. Cephalalgia 23, 961–962 (2003).
   PubMed Web of Science ®Google Scholar
• Krymchantowski AV, Hampshire F. Polytherapy in migraine prevention. Clinical experience with the combination of a β-blocker plus a tricyclic antidepressant plus a calcium channel blocker. Headache 44, 499–500 (2004).
   Google Scholar
• Headache Classification Committee Of The International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 8(Suppl. 7), 1–96 (1988).
   Web of Science ®Google Scholar
• Silberstein SD, Lipton RB, Sliwinski M. Classification of daily and near-daily headaches: field trial of revised criteria. Neurology 47, 871–875 (1996).
   PubMed Web of Science ®Google Scholar
• Dodick DW. Acute and prophylactic management of migraine. Clin. Cornerstone 4, 36–52 (2001).
   PubMedGoogle Scholar
• Ferrari MD, Haan J. Drug treatment of migraine attacks. In: Headache. Blue Books of Practical Neurology. Goadsby P, Silberstein SD (Eds), Butterworth-Heinemann, MA, USA, 117–130 (1997).
   Google Scholar
• Lipton RB, Diamond S, Reed M, Diamond ML, Stewart WF. Migraine diagnosis and treatment: results from the American Migraine Study II. Headache 41, 638–645 (2001).
   PubMed Web of Science ®Google Scholar
• Peroutka SJ. Beyond monotherapy: rational polytherapy in migraine. Headache 38, 18–22 (1998).
   PubMedGoogle Scholar
• Bates D, Ashford E, Dawson R et al. Subcutaneous sumatriptan during the migraine aura. Neurology 44, 1587–1592 (1994).
   PubMed Web of Science ®Google Scholar
• Visser WH, de Vriend RH, Jaspers NHWM, Ferrari MD. Sumatriptan – nonresponders: a survey in 366 migraine patients. Headache 36, 471–475 (1996).
   PubMed Web of Science ®Google Scholar
• Dahlof CG. How does sumatriptan perform in clinical practice? Cephalalgia 15(Suppl. 15), 21–28 (1995).
   PubMedGoogle Scholar
• Visser WH, de Vriend RH, Jaspers WM, Ferrari MD. Sumatriptan in clinical practice: a 2-year review of 453 migraine patients. Neurology 47, 46–51 (1996).
   PubMed Web of Science ®Google Scholar
• Saxena P, Tfelt-Hansen P. Triptans, 5-HT1B/1D receptor agonists in the acute treatment of migraine. In: The Headaches. Second Edition. Olesen J, Tfelt-Hansen P, Welch KMA (Eds), Lippincott Williams & Wilkins, PA, USA, 411–438 (2000).
   Google Scholar
• Tfelt-Hansen P, McEwen J. Nonsteroidal anti-inflammatory drugs in the acute treatment of migraine. In: The Headaches. Second Edition. Olesen J, Tfelt-Hansen P, Welch KMA (Eds), Lippincott Williams & Wilkins, PA, USA, 391–397 (2000).
   Google Scholar
• Lipton RB, Hamelsky SW, Dayno JM. What do patients with migraine want from acute migraine treatment? Headache 42(Suppl. 1), 3–9 (2002).
   PubMed Web of Science ®Google Scholar
• Krymchantowski AV, Barbosa JS. Rizatriptan combined with rofecoxib vs. rizatriptan for the acute treatment of migraine: an open label pilot study. Cephalalgia 22, 309–312 (2002).
   PubMed Web of Science ®Google Scholar
• Ferrari MD, James MH, Bates D et al. Oral sumatriptan: possible benefit of a second dose, and incidence and treatment of headache recurrences. Cephalalgia 14, 330–338 (1994).
   PubMed Web of Science ®Google Scholar
• Burstein R, Collins B, Jakubowski M. Defeating migraine pain with triptans: a race against the development of cutaneous allodynia. Ann. Neurol. 55, 19–26 (2004).
   PubMed Web of Science ®Google Scholar
• Lance JW. Headache. Ann. Neurol. 10, 1–10 (1981).
   PubMed Web of Science ®Google Scholar
• Wilkinson M. Treatment of the acute migraine attack – current status. Cephalalgia 3, 61–67 (1983).
   PubMedGoogle Scholar
• The Oral Sumatriptan and Aspirin plus Metoclopramide Comparative Study Group. A study to compare oral sumatriptan with oral aspirin plus metoclopramide in the acute treatment of migraine. Eur. Neurol. 32, 177–184 (1992).
   PubMed Web of Science ®Google Scholar
• Tfelt-Hansen P, Henry P, Mulder LJ, Scheldewaert RG, Schoenen J, Chazot G. The effectiveness of combined oral lysine acetylsalicylate and metoclopramide compared with oral sumatriptan for migraine. Lancet 346, 923–926 (1995).
   PubMed Web of Science ®Google Scholar
• Diener HC, Pfaffenrath V, Pageler L, Peil H, Aicher B. The fixed combination of acetylsalicylic acid, paracetamol and caffeine is more effective than single substances and dual combination for the treatment of headache: a multicentre, randomized, double-blind, single-dose, placebo-controlled parallel group study. Cephalalgia 25, 776–787 (2005).
   PubMed Web of Science ®Google Scholar
• Goldstein J, Silberstein SD, Saper JR et al. Acetaminophen, aspirin, and caffeine versus sumatriptan in the early treatment of migraine: results from the ASSET trial. Headache 45, 973–982 (2005).
   PubMed Web of Science ®Google Scholar
• Krymchantowski AV. Naproxen sodium decreases migraine recurrence when administered with sumatriptan. Arq. Neuropsiquiatr. 58(2-B), 428–430 (2000).
   PubMed Web of Science ®Google Scholar
• Smith TR, Sunshine A, Stark SR, Littlefield DE, Spruill SE, Alexander J. Sumatriptan and naproxen sodium for the acute treatment of migraine. Headache 45, 983–991 (2005).
   PubMed Web of Science ®Google Scholar
• Krymchantowski AV, Bigal ME, Moreira PF. Rizatriptan vs. rizatriptan plus rofecoxib vs. rizatriptan plus tolfenamic acid in the acute treatment of migraine. BMC Neurol. 28(4), 10 (2004).
   Google Scholar
• Burstein R, Levy D, Collins B, Jakubowski M. Therapeutic approach to migraine with allodynia. Neurology 64(Suppl. 1), (2005) (Abstract 151).
   PubMedGoogle Scholar
• Krymchantowski AV, Bigal ME, Moreira PF. Rizatriptan vs. rizatriptan plus trimebutine for the acute treatment of migraine: a double-blind, randomized, cross-over, placebo-controlled study. Neurology 64(Suppl. 1), (2005) (Abstract 348).
   Google Scholar
• Brandes J, O’Carroll PC, Mannix L, Lener SE, Littlefield D, Alexander WJ. Therapeutic clinical benefits of a new single-tablet formulation of sumatriptan formulated with RT technology and naproxen sodium. Cephalalgia 25, 860 (2005).
   Web of Science ®Google Scholar
• Pascual J, Lainez M, Leira R. Bending the rule of monotherapy for migraine prevention? Headache 45, 748–750 (2005).
   PubMedGoogle Scholar
• Krymchantowski AV. Acute treatment of migraine. Breaking the paradigm of monotherapy. BMC Neurol. 28(4), 1–4 (2004).
   Google Scholar
• Ramadan NM. Targeting therapy for migraine: what to treat? Neurology 64, S4–S8 (2005).
   Google Scholar
• Waeber C, Moskowitz MA. Migraine as an inflammatory disorder. Neurology 64, S9–S15 (2005).
   PubMed Web of Science ®Google Scholar
• Burstein R, Jakubowski M. Implications of multimechanism therapy: when to treat? Neurology 64, S16–S20 (2005).
   Google Scholar
• Fox AW, Kori SH. Pharmacokinetic opportunities for combination therapy in migraine. Neurology 64, S21–S25 (2005).
   PubMedGoogle Scholar